BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24953334)

  • 41. RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death.
    Ader I; Toulas C; Dalenc F; Delmas C; Bonnet J; Cohen-Jonathan E; Favre G
    Oncogene; 2002 Sep; 21(39):5998-6006. PubMed ID: 12203112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
    Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.
    Weppler SA; Krause M; Zyromska A; Lambin P; Baumann M; Wouters BG
    Radiother Oncol; 2007 Jan; 82(1):96-104. PubMed ID: 17161482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells.
    Malavaud B; Pedron S; Sordello S; Mazerolles C; Billottet C; Thiery JP; Jouanneau J; Plouët J
    Oncogene; 2004 Sep; 23(40):6769-78. PubMed ID: 15273729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
    Arbeit JM; Olson DC; Hanahan D
    Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells.
    Hurley MM; Tetradis S; Huang YF; Hock J; Kream BE; Raisz LG; Sabbieti MG
    J Bone Miner Res; 1999 May; 14(5):776-83. PubMed ID: 10320526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example].
    Chargari C; Moncharmont C; Lévy A; Guy JB; Bertrand G; Guilbert M; Rousseau C; Védrine L; Alphonse G; Toillon RA; Rodriguez-Lafrasse C; Deutsch E; Magné N
    Bull Cancer; 2012 Dec; 99(12):1153-60. PubMed ID: 23228708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The fibroblast growth factor receptor antagonist SSR128129E inhibits fat accumulation via suppressing adipogenesis in mice.
    Zhang X; Wen X; Hu G; Zhang Q; Sun Q; Jia Y; Liu Y; Lin H; Li H
    Mol Biol Rep; 2022 Sep; 49(9):8641-8649. PubMed ID: 35731366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells.
    Merle P; Evrard B; Petitjean A; Lehn JM; Teulade-Fichou MP; Chautard E; De Cian A; Guittat L; Tran PL; Mergny JL; Verrelle P; Tchirkov A
    Mol Cancer Ther; 2011 Oct; 10(10):1784-95. PubMed ID: 21987532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compound.
    Merle P; Gueugneau M; Teulade-Fichou MP; Müller-Barthélémy M; Amiard S; Chautard E; Guetta C; Dedieu V; Communal Y; Mergny JL; Gallego M; White C; Verrelle P; Tchirkov A
    Sci Rep; 2015 Nov; 5():16255. PubMed ID: 26542881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FGF2: a novel druggable target for glioblastoma?
    Jimenez-Pascual A; Mitchell K; Siebzehnrubl FA; Lathia JD
    Expert Opin Ther Targets; 2020 Apr; 24(4):311-318. PubMed ID: 32174197
    [No Abstract]   [Full Text] [Related]  

  • 54. A role for ceruloplasmin in the control of human glioblastoma cell responses to radiation.
    Roy C; Avril S; Legendre C; Lelièvre B; Vellenriter H; Boni S; Cayon J; Guillet C; Guilloux Y; Chérel M; Hindré F; Garcion E
    BMC Cancer; 2022 Aug; 22(1):843. PubMed ID: 35918659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism.
    Shen H; Hau E; Joshi S; Dilda PJ; McDonald KL
    Mol Cancer Ther; 2015 Aug; 14(8):1794-804. PubMed ID: 26063767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation.
    Heckler M; Osterberg N; Guenzle J; Thiede-Stan NK; Reichardt W; Weidensteiner C; Saavedra JE; Weyerbrock A
    Tumour Biol; 2017 Jun; 39(6):1010428317703922. PubMed ID: 28653883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice.
    Henke G; Meier V; Lindner LH; Eibl H; Bamberg M; Belka C; Budach W; Jendrossek V
    Radiat Oncol; 2012 Oct; 7():172. PubMed ID: 23078969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the Combined Treatment with a G-Quadruplex-Stabilizing Ligand and Photon Beams on Glioblastoma Stem-like Cells: A Magnetic Resonance Study.
    Palma A; Grande S; Luciani AM; Ricci-Vitiani L; Buccarelli M; Pallini R; Triveri A; Pirota V; Doria F; D'Alessandris QG; Berardinelli F; Antoccia A; Rosi A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Radioresponse and Radiosensitizers in Glioblastoma Organotypic Cultures.
    Bayin NS; Ma L; Placantonakis DG; Barcellos-Hoff MH
    Methods Mol Biol; 2018; 1741():171-182. PubMed ID: 29392699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient mice.
    Dol-Gleizes F; Delesque-Touchard N; Marès AM; Nestor AL; Schaeffer P; Bono F
    PLoS One; 2013; 8(11):e80027. PubMed ID: 24224032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.